Discovery proteomics detects expression trends associated with resistance to the most commonly used chemotherapies in esophageal adenocarcinoma

Mittal, S., Abdo, J., & Agrawal, D. (2020). Discovery proteomics detects expression trends associated with resistance to the most commonly used chemotherapies in esophageal adenocarcinoma. European Journal of Cancer, 138, S40. https://doi.org/10.1016/s0959-8049(20)31180-1